Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers
Tài liệu tham khảo
Bai, 1995, Targeting of peptide and protein drugs to specific sites in the oral route, Crit. Rev. Ther. Drug Carrier Syst., 12, 339, 10.1615/CritRevTherDrugCarrierSyst.v12.i4.30
Aungst, 1996, Enhancement of the intestinal absorption of peptides and non-peptides, J. Control. Release, 41, 19, 10.1016/0168-3659(96)01353-3
Touitou, 1992, Enhancement of intestinal peptide absorption, J. Control. Release, 21, 139, 10.1016/0168-3659(92)90015-J
Borchard, 1996, The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption III: effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro, J. Control. Release, 39, 131, 10.1016/0168-3659(95)00146-8
Hurni, 1993, Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy, J. Pharmacol. Exp. Ther., 267, 942
Uchiyama, 1996, Effectiveness and toxicity screening of various absorption enhancers in the large intestine: intestinal absorption of phenol red and protein and phospholipid release from the intestinal membrane, Biol. Pharm. Bull., 19, 1618, 10.1248/bpb.19.1618
Anderberg, 1992, Epithelial transport of drugs in cell culture. VI: Effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells, J. Pharm. Sci., 81, 879, 10.1002/jps.2600810908
Hirano, 1988, Biocompatibility of chitosan by oral and intravenous administration, Polym. Eng. Sci., 59, 897
Chandy, 1990, Chitosan as a biomaterial, Biomater. Art. Cells Art. Org., 18, 1, 10.3109/10731199009117286
Aspden, 1997, The effect of chronic nasal application of chitosan solutions on cilia beat frequency in guinea pigs, Int. J. Pharm., 153, 137, 10.1016/S0378-5173(97)04914-4
Henriksen, 1993, Use of chitosan and chitosan malate as an excipient in wet granulation of three water soluble drugs, Int. J. Pharm., 98, 181, 10.1016/0378-5173(93)90055-K
Sawayanagi, 1982, Directly compressed tablets containing chitin or chitosan in addition to lactose or potato starch, Chem. Pharm. Bull., 30, 2935, 10.1248/cpb.30.2935
Kristl, 1993, Hydrocolloids and gels of chitosan as drug carriers, Int. J. Pharm., 99, 13, 10.1016/0378-5173(93)90317-9
Remuñan-López, 1996, Effect of formulation and process variables on the formulation of chitosan-gelatin coacervates, Int. J. Pharm., 135, 63, 10.1016/0378-5173(95)04347-0
Berthold, 1996, Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs, J. Control. Release, 39, 17, 10.1016/0168-3659(95)00129-8
Liu, 1997, Controlled release of interleukin-2 for tumor immunotherapy using alginate/chitosan porous microspheres, J. Control. Release, 43, 65, 10.1016/S0168-3659(96)01471-X
Oungbho, 1997, Chitosan sponges as sustained release drug carriers, Int. J. Pharm., 156, 229, 10.1016/S0378-5173(97)00201-9
Lehr, 1992, In vitro evaluation of mucoadhesion properties of chitosan and some other natural polymers, Int. J. Pharm., 78, 43, 10.1016/0378-5173(92)90353-4
Illum, 1994, Chitosan as a novel nasal delivery system for peptide drugs, Pharm. Res., 11, 1186, 10.1023/A:1018901302450
Aspden, 1996, Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models, Eur. J. Pharm. Sci., 4, 23, 10.1016/0928-0987(95)00026-7
Lueßen, 1997, Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro, J. Control. Release, 45, 15, 10.1016/S0168-3659(96)01536-2
Lueßen, 1996, Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo, Pharm. Res., 13, 1666, 10.1023/A:1016488623022
Kotzé, 1998, Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments, Eur. J. Pharm. Sci., 7, 145, 10.1016/S0928-0987(98)00016-5
Sieval, 1998, Preparation and NMR-characterization of highly substituted N-trimethyl chitosan chloride, Carbohydrate Polym., 36, 157, 10.1016/S0144-8617(98)00009-5
le Dung, 1994, Water soluble derivatives obtained by controlled chemical modification of chitosan, Carbohydrate Polym., 24, 209, 10.1016/0144-8617(94)90132-5
Kotzé, 1997, N-Trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2), Pharm. Res., 14, 1197, 10.1023/A:1012106907708
Artursson, 1996, 111
Lindahl, 1997, Characterization of fluids from the stomach and proximal jejunum in men and women, Pharm. Res., 14, 497, 10.1023/A:1012107801889
Choksakulnimitr, 1995, In vitro cytotoxicity of macromolecules in different cell culture systems, J. Control. Release, 34, 233, 10.1016/0168-3659(95)00007-U
Artursson, 1994, Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2), Pharm. Res., 11, 1358, 10.1023/A:1018967116988